You are here

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Nail Psoriasis, Plaque Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 18 years of age or older

- Active, stable plaque psoriasis defined by the following criteria:

- Body surface area (BSA) ≥ 10 % at screening and baseline

- Or, PASI >10 at screening and baseline

- Or, PGA of Psoriasis status of moderate or worse (moderate, marked, or severe) at
screening and baseline

- Or, DLQI > 10 at baseline

- Active fingernail psoriasis defined as target fingernail NAPSI ≥ 2 and overall NAPSI >
14 - Target nail is defined as the nail with the highest nail score (matrix+bed
scores) at baseline. Should more than one fingernail have the same score, the target
fingernail will be chosen by the investigator.

- Failure of at least one systemic psoriasis therapy for nail psoriasis

- Eligible to receive biologic therapy for psoriasis in accordance to local guidelines

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence of Skin conditions other than psoriasis

- Psoralen plus ultraviolet radiation (PUVA), cyclosporine, alefacept, methotrexate,
acitretin, or any other systemic anti-psoriasis therapy within 28 days of study drug
initiation

- Prior exposure to any TNF-inhibitor. Prior exposure to efalizumab

NCT00581100
Pfizer
Completed
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now